MRC1 and neoplasm: Stage at diagnosis was similar between MMR-deficient, and Lynch syndromes patients, both of these groups were significantly less likely to be diagnosed as stage I when compared to MMR-intact tumours (70% and 67% versus 81%, respectively, p < 0.01).